Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm study of HX575 epoetin alfa in anemia associated with chronic kidney disease
2011-002871-40Phase 3Completed
- Sponsor
- Hexal AG
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of epoetin alfa in anemia of renal disease, sponsored by Hexal AG. Primary endpoint: Incidence of antibody formation against epoetin. Started Nov 2011; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2011-002871-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002871-40.